Lv1
68 积分 2024-08-05 加入
Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
1天前
待确认
Epidemiology and genomics of prostate cancer in Asian men
8天前
已完结
Treatment with darolutamide +/- radiation therapy for patients with a castration resistant cancer and metastases detected by functional imaging
15天前
已关闭
PSMAddition: Phase 3 Trial of [177lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer
15天前
已完结
Financial Difficulties and Long-Term Oncological Outcomes Following Prostate Radiotherapy and Androgen Deprivation Therapy – Post-Hoc Analyses of TROG0304/ RADAR Trial
15天前
已完结
Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial
15天前
已完结
Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: data from 2 Phase III Trials
15天前
已完结
PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer
15天前
已完结
LH-RH analogues: review of international clinical experience
16天前
已关闭
A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study
16天前
已关闭
皖公网安备34019202002308
